Swiss National Bank’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-95,600
| Closed | -$527K | – | 2819 |
|
2022
Q1 | $527K | Buy |
95,600
+6,700
| +8% | +$36.9K | ﹤0.01% | 2595 |
|
2021
Q4 | $861K | Hold |
88,900
| – | – | ﹤0.01% | 2530 |
|
2021
Q3 | $1.59M | Buy |
88,900
+8,400
| +10% | +$150K | ﹤0.01% | 2196 |
|
2021
Q2 | $1.97M | Sell |
80,500
-2,400
| -3% | -$58.6K | ﹤0.01% | 2109 |
|
2021
Q1 | $2.2M | Buy |
82,900
+10,000
| +14% | +$265K | ﹤0.01% | 1941 |
|
2020
Q4 | $553K | Hold |
72,900
| – | – | ﹤0.01% | 2446 |
|
2020
Q3 | $365K | Hold |
72,900
| – | – | ﹤0.01% | 2405 |
|
2020
Q2 | $436K | Buy |
72,900
+12,000
| +20% | +$71.8K | ﹤0.01% | 2403 |
|
2020
Q1 | $271K | Hold |
60,900
| – | – | ﹤0.01% | 2365 |
|
2019
Q4 | $579K | Buy |
60,900
+1,500
| +3% | +$14.3K | ﹤0.01% | 2382 |
|
2019
Q3 | $466K | Hold |
59,400
| – | – | ﹤0.01% | 2381 |
|
2019
Q2 | $934K | Buy |
+59,400
| New | +$934K | ﹤0.01% | 2152 |
|